Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
5 items
The FDA granted Fast Track designation to bempikibart, a novel anti-IL-7Rα antibody from Q32 Bio, for the treatment of alopecia areata, acc...
View — FDA Grants Fast Track Designation to Bempikibart for Alopecia Areata, Spotlighting New Immune Target »Extended treatment with Nektar Therapeutics' rezpegaldesleukin produced clinically meaningful hair regrowth in 27% of participants with seve...
View — Rezpeg Produces Meaningful Hair Regrowth at One Year in Severe Alopecia Areata, Phase 3 Plans Announced »The European Commission has approved AbbVie's Rinvoq (upadacitinib) for both severe alopecia areata and non-segmental vitiligo, making it th...
View — AbbVie's Rinvoq Wins EU Approval for Alopecia Areata and Vitiligo »